Sumex 1% w/v, solution for injection for cattle

Χώρα: Ιρλανδία

Γλώσσα: Αγγλικά

Πηγή: HPRA (Health Products Regulatory Authority)

Δραστική ουσία:

Ivermectin

Διαθέσιμο από:

Chanelle Animal Health Ltd.

Φαρμακολογική κατηγορία (ATC):

QP54AA01

INN (Διεθνής Όνομα):

Ivermectin

Δοσολογία:

1.0 percent weight/volume

Φαρμακοτεχνική μορφή:

Solution for injection

Τρόπος διάθεσης:

LM: Licensed Merchant as defined in relevant national legislation

Θεραπευτική ομάδα:

Cattle

Θεραπευτική περιοχή:

ivermectin

Θεραπευτικές ενδείξεις:

Endectoparasiticides

Καθεστώς αδειοδότησης:

Authorised

Ημερομηνία της άδειας:

2002-06-28

Αρχείο Π.Χ.Π.

SUMMARY OF PRODUCT CHARACTERISTICS
1 NAME OF THE VETERINARY MEDICINAL PRODUCT
Sumex 1% w/v, solution for injection for cattle
2 QUALITATIVE AND QUANTITATIVE COMPOSITION
Active Substance
Ivermectin
1.0 % w/v (10 mg/ml)
For a full list of excipients, see section 6.1
3 PHARMACEUTICAL FORM
Solution for injection
Clear, colourless to slightly yellow solution
4 CLINICAL PARTICULARS
4.1 TARGET SPECIES
Cattle (Beef and non lactating cattle)
4.2 INDICATIONS FOR USE, SPECIFYING THE TARGET SPECIES
The product is indicated for the effective treatment of the following
harmful parasites of cattle:
GASTRO-INTESTINAL ROUNDWORMS:
_Ostertagia_ spp (including inhibited_ O. ostertagi_
_(adult and L4_)),
_Haemonchus placei (adult and L4_),
_Trichostrongylus spp (adult and L4_),
_Cooperia_ spp_ (adult and L4_),
_Nematodirus spp (adult_),
LUNGWORMS (adult and fourth stage larvae):
_Dictyocaulus viviparus_
WARBLES (parasitic stages):
_Hypoderma spp_
MANGE MITES:
_Psoroptes bovis_
_Sarcoptes scabiei_ var._ bovis_.
SUCKING LICE:
_Linognathus vituli_,
_Haematopinus eurysternus_
PERSISTENT ACTIVITY
Treatment at the recommended dose rate controls re-infection with_
Haemonchus placei_ and_ Cooperia spp._ acquired up
H
E
A
L
T
H
P
R
O
D
U
C
T
S
R
E
G
U
L
A
T
O
R
Y
A
U
T
H
O
R
I
T
Y
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
_D_
_a_
_t_
_e_
_ _
_P_
_r_
_i_
_n_
_t_
_e_
_d_
_ _
_2_
_3_
_/_
_1_
_2_
_/_
_2_
_0_
_1_
_5_
_C_
_R_
_N_
_ _
_7_
_0_
_2_
_2_
_4_
_9_
_1_
_p_
_a_
_g_
_e_
_ _
_n_
_u_
_m_
_b_
_e_
_r_
_:_
_ _
_1_
to 14 days after treatment,
_Ostertagia ostertagi_
acquired up to 21 days after treatment
and_ Dictyocaulus vivi